By


ENB Therapeutics Announces Poster Presentation at the 2022 Summit for Cancer Immunotherapy

ENB is developing first in class small molecule ENB-003 to selectively targeting the ETB receptor – a novel immune checkpoint

See more here

By


ImmunoGenesis to Present Pre-Clinical Data from Lead Program at Society for Immunotherapy of Cancer Conference

See more here

By


Senzo Receives Funding from the Biomedical Advanced Research and Development Authority (BARDA) to Advance Its PCR-Accurate Lateral Flow COVID-19 Test

See more here

By


Venatorx Pharmaceuticals Presents Data on Investigational Cefepime-Taniborbactam at IDWeek 2022

Superior to Meropenem for the Primary Efficacy Endpoint

Safety Profile Consistent with Meropenem

See more here

By


Treventis Awarded $2.97M Grant from the U.S. Department of Defense

Funds for Development of Its Anti-Tau Drug Against Neurodegenerative Diseases

See more here

By


Wellsheet Introduces EHR Workflow Relief to Increase Efficiency During Critical Nursing Shortage

Virtual Nursing Station with Real-Time Notifications Increases Care Team Collaboration and Patient Care Quality

See more here

By


Relmada Therapeutics Announces Top-line Results from Phase 3 RELIANCE III Trial for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder

See more here

By


Annovis Bio Announces Publication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer’s Disease

See more here

By


Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer’s Disease

See more here